Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Büscher R[au]:

Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Warejko JK et al. Clin J Am Soc Nephrol. (2018)

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders. Wehling C et al. Clin Exp Immunol. (2017)

FAT1 mutations cause a glomerulotubular nephropathy. Gee HY et al. Nat Commun. (2016)

Search results

Items: 1 to 50 of 72

1.

Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.

Bartosova M, Schaefer B, Vondrak K, Sallay P, Taylan C, Cerkauskiene R, Dzierzega M, Milosevski-Lomic G, Büscher R, Zaloszyc A, Romero P, Lasitschka F, Warady BA, Schaefer F, Ujszaszi A, Schmitt CP.

Front Physiol. 2019 Apr 2;10:356. doi: 10.3389/fphys.2019.00356. eCollection 2019.

2.

Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.

Shroff R, Smith C, Ranchin B, Bayazit AK, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, Ağbaş A, Aitkenhead H, Anarat A, Aoun B, Aofolaju D, Bakkaloglu SA, Bhowruth D, Borzych-Dużałka D, Bulut IK, Büscher R, Deanfield J, Dempster C, Duzova A, Habbig S, Hayes W, Hegde S, Krid S, Licht C, Litwin M, Mayes M, Mir S, Nemec R, Obrycki L, Paglialonga F, Picca S, Samaille C, Shenoy M, Sinha MD, Spasojevic B, Stronach L, Vidal E, Vondrák K, Yilmaz A, Zaloszyc A, Fischbach M, Schmitt CP, Schaefer F.

J Am Soc Nephrol. 2019 Apr;30(4):678-691. doi: 10.1681/ASN.2018100990. Epub 2019 Mar 7.

PMID:
30846560
3.

Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients.

Blöte R, Memaran N, Borchert-Mörlins B, Thurn-Valsassina D, Goldschmidt I, Beier R, Sauer M, Müller C, Sarganas G, Oh J, Büscher R, Kemper MJ, Sugianto RI, Epping J, Schmidt BMW, Melk A.

Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002675. [Epub ahead of print]

PMID:
30801541
4.

Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.

Shroff R, Bayazit A, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, Agbas A, Anarat A, Aoun B, Bakkaloglu S, Bhowruth D, Borzych-Dużałka D, Bulut IK, Büscher R, Dempster C, Duzova A, Habbig S, Hayes W, Hegde S, Krid S, Licht C, Litwin M, Mayes M, Mir S, Nemec R, Obrycki L, Paglialonga F, Picca S, Ranchin B, Samaille C, Shenoy M, Sinha M, Smith C, Spasojevic B, Vidal E, Vondrák K, Yilmaz A, Zaloszyc A, Fischbach M, Schaefer F, Schmitt CP.

BMC Nephrol. 2018 Aug 10;19(1):199. doi: 10.1186/s12882-018-0998-y.

5.

Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen.

Ruben S, Kreuzer M, Büscher A, Büscher R, Thumfart J, Querfeld U, Staude H, Ahlenstiel-Grunow T, Melk A, Fischer DC, Leifheit-Nestler M, Pape L, Haffner D.

Kidney Blood Press Res. 2018;43(3):793-806. doi: 10.1159/000489915. Epub 2018 May 22.

6.

Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.

Schaefer B, Bartosova M, Macher-Goeppinger S, Sallay P, Vörös P, Ranchin B, Vondrak K, Ariceta G, Zaloszyc A, Bayazit AK, Querfeld U, Cerkauskiene R, Testa S, Taylan C, VandeWalle J, Yap Y, Krmar RT, Büscher R, Mühlig AK, Drozdz D, Caliskan S, Lasitschka F, Fathallah-Shaykh S, Verrina E, Klaus G, Arbeiter K, Bhayadia R, Melk A, Romero P, Warady BA, Schaefer F, Ujszaszi A, Schmitt CP.

Kidney Int. 2018 Aug;94(2):419-429. doi: 10.1016/j.kint.2018.02.022.

PMID:
29776755
7.

Teaching paediatric basic life support in medical schools using peer teaching or video demonstration: A prospective randomised trial.

Stephan F, Groetschel H, Büscher AK, Serdar D, Groes KA, Büscher R.

J Paediatr Child Health. 2018 Sep;54(9):981-986. doi: 10.1111/jpc.13937. Epub 2018 May 13.

PMID:
29754417
8.

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.

Klaus G, Taylan C, Büscher R, Schmitt CP, Pape L, Oh J, Driemeyer J, Galiano M, König J, Schürfeld C, Spitthöver R, Schaefer JR, Weber LT, Heibges A, Klingel R.

Pediatr Nephrol. 2018 Jul;33(7):1199-1208. doi: 10.1007/s00467-018-3906-6. Epub 2018 Mar 3.

PMID:
29502162
9.

Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome.

Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, Lovric S, Ashraf S, Rao J, Hermle T, Jobst-Schwan T, Widmeier E, Majmundar AJ, Schneider R, Gee HY, Schmidt JM, Vivante A, van der Ven AT, Ityel H, Chen J, Sadowski CE, Kohl S, Pabst WL, Nakayama M, Somers MJG, Rodig NM, Daouk G, Baum M, Stein DR, Ferguson MA, Traum AZ, Soliman NA, Kari JA, El Desoky S, Fathy H, Zenker M, Bakkaloglu SA, Müller D, Noyan A, Ozaltin F, Cadnapaphornchai MA, Hashmi S, Hopcian J, Kopp JB, Benador N, Bockenhauer D, Bogdanovic R, Stajić N, Chernin G, Ettenger R, Fehrenbach H, Kemper M, Munarriz RL, Podracka L, Büscher R, Serdaroglu E, Tasic V, Mane S, Lifton RP, Braun DA, Hildebrandt F.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):53-62. doi: 10.2215/CJN.04120417. Epub 2017 Nov 10.

10.

Early Effects of Renal Replacement Therapy on Cardiovascular Comorbidity in Children With End-Stage Kidney Disease: Findings From the 4C-T Study.

Schmidt BMW, Sugianto RI, Thurn D, Azukaitis K, Bayazit AK, Canpolat N, Eroglu AG, Caliskan S, Doyon A, Duzova A, Karagoz T, Anarat A, Deveci M, Mir S, Ranchin B, Shroff R, Baskin E, Litwin M, Özcakar ZB, Büscher R, Soylemezoglu O, Dusek J, Kemper MJ, Matteucci MC, Habbig S, Laube G, Wühl E, Querfeld U, Sander A, Schaefer F, Melk A; 4C Study Consortium.

Transplantation. 2018 Mar;102(3):484-492. doi: 10.1097/TP.0000000000001948.

PMID:
28926375
11.

Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.

Prusinskas B, Kathemann S, Pilic D, Hegen B, Küster P, Keitel V, Häussinger D, Büscher R, Baba HA, Hoyer PF, Lainka E.

Transplant Proc. 2017 Sep;49(7):1628-1633. doi: 10.1016/j.transproceed.2017.06.011.

PMID:
28838453
12.

Factors associated with cardiovascular target organ damage in children after renal transplantation.

Borchert-Mörlins B, Thurn D, Schmidt BMW, Büscher AK, Oh J, Kier T, Bauer E, Baig S, Kanzelmeyer N, Kemper MJ, Büscher R, Melk A.

Pediatr Nephrol. 2017 Nov;32(11):2143-2154. doi: 10.1007/s00467-017-3771-8. Epub 2017 Aug 13.

PMID:
28804814
13.

Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.

Stehling F, Büscher R, Grosse-Onnebrink J, Hoyer PF, Mellies U.

Pulm Med. 2017;2017:2602653. doi: 10.1155/2017/2602653. Epub 2017 Jan 4.

14.

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.

Wehling C, Amon O, Bommer M, Hoppe B, Kentouche K, Schalk G, Weimer R, Wiesener M, Hohenstein B, Tönshoff B, Büscher R, Fehrenbach H, Gök ÖN, Kirschfink M.

Clin Exp Immunol. 2017 Feb;187(2):304-315. doi: 10.1111/cei.12890. Epub 2016 Nov 25.

15.

FAT1 mutations cause a glomerulotubular nephropathy.

Gee HY, Sadowski CE, Aggarwal PK, Porath JD, Yakulov TA, Schueler M, Lovric S, Ashraf S, Braun DA, Halbritter J, Fang H, Airik R, Vega-Warner V, Cho KJ, Chan TA, Morris LG, ffrench-Constant C, Allen N, McNeill H, Büscher R, Kyrieleis H, Wallot M, Gaspert A, Kistler T, Milford DV, Saleem MA, Keng WT, Alexander SI, Valentini RP, Licht C, Teh JC, Bogdanovic R, Koziell A, Bierzynska A, Soliman NA, Otto EA, Lifton RP, Holzman LB, Sibinga NE, Walz G, Tufro A, Hildebrandt F.

Nat Commun. 2016 Feb 24;7:10822. doi: 10.1038/ncomms10822.

16.

Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.

Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Büscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F.

Nat Genet. 2016 Apr;48(4):457-65. doi: 10.1038/ng.3512. Epub 2016 Feb 15.

17.

Combined liver and kidney transplantation and kidney after liver transplantation in children: Indication, postoperative outcome, and long-term results.

Büscher R, Büscher AK, Cetiner M, Treckmann JW, Paul A, Vester U, Hoyer PF.

Pediatr Transplant. 2015 Dec;19(8):858-65. doi: 10.1111/petr.12595. Epub 2015 Sep 5.

PMID:
26341656
18.

Automated Greulich-Pyle bone age determination in children with chronic kidney disease.

Nüsken E, Imschinetzki D, Nüsken KD, Körber F, Mentzel HJ, Peitz J, Bald M, Büscher R, John U, Klaus G, Konrad M, Pape L, Tönshoff B, Martin D, Weber L, Dötsch J.

Pediatr Nephrol. 2015 Jul;30(7):1173-9. doi: 10.1007/s00467-015-3042-5. Epub 2015 Mar 19.

PMID:
25787071
19.

[Childhood ureteropelvic junction obstruction in a regional treatment center: spectrum and therapy].

Eisenhardt A, Rübben H, Rübben I, Dakkak D, Hoyer PF, Büscher R.

Urologe A. 2013 Dec;52(12):1698-704. doi: 10.1007/s00120-013-3346-7. German.

PMID:
24258353
20.

Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.

Büscher R, Büscher AK, Weber S, Mohr J, Hegen B, Vester U, Hoyer PF.

Pediatr Nephrol. 2014 Oct;29(10):1915-25. doi: 10.1007/s00467-013-2634-1. Epub 2013 Oct 10. Review.

PMID:
24114580
21.

Evaluation of the peer teaching program at the University Children´s Hospital Essen - a single center experience.

Büscher R, Weber D, Büscher A, Hölscher M, Pohlhuis S, Groes B, Hoyer PF.

GMS Z Med Ausbild. 2013 May 15;30(2):Doc25. doi: 10.3205/zma000868. Print 2013.

22.

COL4A5-associated X-linked Alport syndrome in a female patient with early inner ear deafness due to a mutation in MYH9.

Strasser K, Hoefele J, Bergmann C, Büscher AK, Büscher R, Hoyer PF, Weber S.

Nephrol Dial Transplant. 2012 Nov;27(11):4236-40. doi: 10.1093/ndt/gfs468.

PMID:
23144074
23.

Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones.

Büscher AK, Cetiner M, Büscher R, Wingen AM, Hauffa BP, Hoyer PF.

Pediatr Nephrol. 2012 Nov;27(11):2065-2071. doi: 10.1007/s00467-012-2220-y. Epub 2012 Jun 5.

PMID:
22669322
24.

Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth.

Büscher AK, Büscher R, Pridzun L, Langkamp M, Wachendorfer N, Hoyer PF, Ranke MB, Hauffa BP.

Eur J Endocrinol. 2012 May;166(5):923-31. doi: 10.1530/EJE-11-0923. Epub 2012 Feb 8.

PMID:
22318747
25.

Quantitative real-time ARMS-qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients.

Hoerning A, Kalkavan H, Rehme C, Menke J, Worm K, Garritsen HS, Büscher R, Hoyer PF.

Pediatr Transplant. 2011 Dec;15(8):809-18. doi: 10.1111/j.1399-3046.2011.01581.x. Epub 2011 Oct 4.

PMID:
21967552
26.

Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry.

Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Büscher R, Salas P, Patel H, Drozdz D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1926-33. doi: 10.2215/CJN.05990710. Epub 2011 Jul 7.

27.

Donor and recipient ACE I/D genotype are associated with loss of renal function in children following renal transplantation.

Büscher R, Nagel D, Finkelberg I, Büscher AK, Wingen AM, Kranz B, Vester U, Hoyer PF.

Pediatr Transplant. 2011 Mar;15(2):214-20. doi: 10.1111/j.1399-3046.2010.01449.x.

PMID:
21309964
28.

Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.

Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Bröking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2075-84. doi: 10.2215/CJN.01190210. Epub 2010 Aug 26. Erratum in: Clin J Am Soc Nephrol. 2012 Aug;7(8):1372-4.

29.

Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease.

Büscher AK, Büscher R, Hauffa BP, Hoyer PF.

Pediatr Nephrol. 2010 Nov;25(11):2295-301. doi: 10.1007/s00467-010-1588-9. Epub 2010 Jul 6.

PMID:
20607302
30.

Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding.

Kreuzer M, Bonzel KE, Büscher R, Offner G, Ehrich JH, Pape L.

Nephrol Dial Transplant. 2010 Oct;25(10):3337-42. doi: 10.1093/ndt/gfq225. Epub 2010 Apr 26.

PMID:
20466660
31.

Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism.

Arbeiter AK, Kranz B, Wingen AM, Bonzel KE, Dohna-Schwake C, Hanssler L, Neudorf U, Hoyer PF, Büscher R.

Nephrol Dial Transplant. 2010 Apr;25(4):1257-65. doi: 10.1093/ndt/gfp595. Epub 2009 Nov 23.

PMID:
19934086
32.

Wear mechanisms in metal-on-metal bearings: the importance of tribochemical reaction layers.

Wimmer MA, Fischer A, Büscher R, Pourzal R, Sprecher C, Hauert R, Jacobs JJ.

J Orthop Res. 2010 Apr;28(4):436-43. doi: 10.1002/jor.21020.

33.

Beta2-adrenergic receptor gene polymorphisms: will the important one please step forward?

Michel MC, Büscher R.

J Am Coll Cardiol. 2008 Oct 21;52(17):1389-90. doi: 10.1016/j.jacc.2008.07.040. No abstract available.

34.

Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.

Arbeiter AK, Büscher R, Petersenn S, Hauffa BP, Mann K, Hoyer PF.

Nephrol Dial Transplant. 2009 Feb;24(2):643-6. doi: 10.1093/ndt/gfn529. Epub 2008 Sep 22.

PMID:
18809976
35.

Nephrectomy in an autosomal recessive polycystic kidney disease (ARPKD) patient with rapid kidney enlargement and increased expression of EGFR.

Arbeiter A, Büscher R, Bonzel KE, Wingen AM, Vester U, Wohlschläger J, Zerres K, Nürnberger J, Bergmann C, Hoyer PF.

Nephrol Dial Transplant. 2008 Sep;23(9):3026-9. doi: 10.1093/ndt/gfn288. Epub 2008 May 23. No abstract available.

PMID:
18503009
36.

Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years.

Kranz B, Vester U, Büscher R, Wingen AM, Hoyer PF.

Pediatr Nephrol. 2008 Apr;23(4):581-6. doi: 10.1007/s00467-007-0709-6. Epub 2008 Jan 16.

37.

Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?

Büscher R, Grasemann H.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Nov;374(2):65-77. Epub 2006 Oct 11. Review.

PMID:
17033796
38.

[Pressfit of equatorially roughened cementless acetabular components--a finite element analysis].

von Knoch M, Pandorf T, Büscher R, Piotrowski A, von Knoch F, Patsalis T, Wedemeyer C, Marx A, Fischer A, Löer F, Saxler G.

Biomed Tech (Berl). 2006 Apr;51(1):21-6. German.

PMID:
16771126
39.

P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx.

Büscher R, Hoerning A, Patel HH, Zhang S, Arthur DB, Grasemann H, Ratjen F, Insel PA.

Pharmacogenet Genomics. 2006 Mar;16(3):199-205.

PMID:
16495779
40.

Geometry and spectrum of Casimir forces.

Büscher R, Emig T.

Phys Rev Lett. 2005 Apr 8;94(13):133901. Epub 2005 Apr 7.

PMID:
15903990
41.

Human adenosine 2B receptor: SNP discovery and evaluation of expression in patients with cystic fibrosis.

Tang CM, Hoerning A, Büscher R, O'Connor DT, Ratjen F, Grasemann H, Insel PA.

Pharmacogenet Genomics. 2005 May;15(5):321-7.

PMID:
15864133
42.

The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1.

Vester U, Kranz B, Zimmermann S, Büscher R, Hoyer PF.

Pediatr Nephrol. 2005 Apr;20(4):478-81. Epub 2005 Feb 17.

PMID:
15717164
43.

Is cyclic AMP formation desensitized in patients with end-stage renal failure?

Leineweber K, Schwiebert C, Büscher R, Michel MC.

Auton Autacoid Pharmacol. 2005 Jan;25(1):25-32.

PMID:
15659151
44.

Subsurface microstructure of metal-on-metal hip joints and its relationship to wear particle generation.

Büscher R, Täger G, Dudzinski W, Gleising B, Wimmer MA, Fischer A.

J Biomed Mater Res B Appl Biomater. 2005 Jan 15;72(1):206-14.

PMID:
15497166
45.

Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients.

Büscher R, Vester U, Wingen AM, Hoyer PF.

Pediatr Nephrol. 2004 Nov;19(11):1202-11. Review.

PMID:
15365804
46.

Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis.

Büscher R, Vij O, Hudde T, Hoyer PF, Vester U.

Pediatr Nephrol. 2004 May;19(5):558-60. Epub 2004 Mar 11.

PMID:
15015064
47.

Beta-adrenoceptor polymorphisms.

Leineweber K, Büscher R, Bruck H, Brodde OE.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):1-22. Epub 2003 Nov 28. Review.

PMID:
14647973
48.

The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo.

Bruck H, Leineweber K, Büscher R, Ulrich A, Radke J, Insel PA, Brodde OE.

Pharmacogenetics. 2003 Feb;13(2):59-66.

PMID:
12563174
49.

Effects of sex and of gene variants in constitutive nitric oxide synthases on exhaled nitric oxide.

Grasemann H, Storm van's Gravesande K, Buscher R, Drazen JM, Ratjen F.

Am J Respir Crit Care Med. 2003 Apr 15;167(8):1113-6. Epub 2003 Jan 16.

PMID:
12531780
50.

Endothelial nitric oxide synthase variants in cystic fibrosis lung disease.

Grasemann H, Storm van's Gravesande K, Buscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F.

Am J Respir Crit Care Med. 2003 Feb 1;167(3):390-4. Epub 2002 Aug 15.

PMID:
12406848

Supplemental Content

Loading ...
Support Center